Safety study of FTL001 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that did not respond to standard treatments, or you cannot take those treatments due to side effects.
- You are 18 to 75 years old and are expected to live at least 3 more months.
- You have at least one tumor that can be measured on a scan (CT or MRI).
- You are able to take care of yourself (ECOG score 0 or 1) and have adequate organ function.
- If you are able to have children, you must agree to use effective birth control during the study and for 6 months after.
- You do not have certain serious heart, lung, or autoimmune conditions. You must not have active hepatitis B, C, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FG-B901, either alone or with chemotherapy, for people with advanced solid tumors that haven't responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth.
This Phase 1 trial tests DFP-14927, a new study drug, in adults with advanced solid tumors that have not responded to standard treatments. It’s designed to see if the drug is safe and to learn how it works in people with limited treatment options.
This trial tests an investigational drug called FTL008.16 for people with advanced solid tumors that may carry a protein called 5T4. The main goal is to see if the drug is safe and tolerable.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial tests a new experimental medicine called SGT003 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the medicine is safe, how the body handles it, and whether it can shrink tumors or slow their growth.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.